Why Did Medline Stock Drop?
For questions about this article or underlying research, email help@trefis.com.
Medline (MDLN) stock fell 5.2% on Thursday, November 12, 2026, while the S&P 500 slipped 0.3%. There was no earnings report from the company in the days just before the move and no filing on the day itself, and 26 of the 29 other health care equipment companies worth $2 billion or more also fell in the same session. So what was going on around Medline that day?
What Was Going On Around Medline On November 12?
AI stocks fell globally on Thursday. Nvidia shares dropped over a leadership crisis at the company, and several analysts downgraded the stock. The Nasdaq Composite fell 0.4% from the day before, and the health care sector fund XLV lost 0.6%. US inflation data was also due.
On its November 4 call, management said cost pressures had intensified through the year, mainly from inflation tied to elevated oil prices, and from mix, as Supply Chain Solutions continues to outgrow the higher-margin Medline Brand. Medline’s gross margin was 24.5% in fiscal Q3 2026, against 26.4% in fiscal Q3 2025.
Did Other Health Care Equipment Stocks Fall Too?
Yes, but by far less. Across Medline’s health care equipment sub-industry, those 29 other companies fell by a median of 0.9%. And one of them fell 5% or more, as Medline did. Medline’s Trefis peers were mixed: McKesson slipped 0.3%, while Johnson & Johnson rose 1.1%. Medline moved in the same direction as its sub-industry, but its drop was more than five times the median fall.
Where Medline Stock Stands After The Drop
A fall this large is not rare for Medline. In the 365 days before November 12, the stock had 8 sessions with a fall at least this large. Its latest move of this size in either direction was an 18.4% rise on November 4, the day of its third-quarter call. Medline still returned 11.3% from October 14 to November 12, Thursday’s drop included, while the S&P 500 lost 1.6%.
The stock closed at $39.98, below its February 24 high of $49.99 for the past year, and well above its September 18 low of $31.64. Medline trades at 1.1 times sales, against 3.2 times for the S&P 500.
Gross margin is the measure to watch when Medline reports its fourth quarter of fiscal 2026. Management expects inflation to weigh more heavily in that quarter than in the third.
Beyond MDLN: A Systematic Way To Invest
Before you decide on MDLN, consider a better choice. Since its September 2020 launch, the Trefis High Quality (HQ) Portfolio has returned 105%, ahead of a benchmark that combines the S&P 500, S&P MidCap and Russell 2000, without betting on one stock.
Spot an error or want more like this? Tell us in 10 seconds.